EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease

Karen Lahme, Wiebke Sachs, Sarah Froembling, Desiree Loreth, Vincent Böttcher-Dierks, Katrin Neumann, Frederik-Michael Hann, Nick Arkan, Michael Brehler, Julia Reichelt, Antonia Sgries, Kristin Surmann und 21 weitere

Cell · 2026-01 · 189 (1) · 123-142.e30

DOI: 10.1016/j.cell.2025.11.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-01. Verfasst von Karen Lahme und 32 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf (UKE), 20246 Hamburg,…. Hauptthemen laut MEDLINE: Podocytes, Autoantibodies, Glomerulonephritis, Membranous, Autoimmune Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Frontier Science Program, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease affects 1 in 10 people worldwide, with damage to specialized blood filter cells of the kidney, called podocytes, playing a critical role. In membranous nephropathy (MN), a major cause of nephrotic syndrome, circulating autoantibodies attack proteins on podocyte foot processes (FPs), damaging the kidney's filtration barrier. Our study shows that these autoantibodies trigger the formation of antigen-autoantibody aggregates on the podocyte FP plasma membrane. These aggregates bud off as stalked vesicles, termed autoimmunoglobulin-triggered extracellular vesicles (AIT-EVs), which are released into the urine. AIT-EVs carry disease-causing autoantibodies, their target antigens, essential FP proteins, and disease-associated stressors representing a mechanism for removing immune complexes (ICs) and waste. However, their excessive release leads to FP effacement and podocyte dysfunction. In MN patients, urinary AIT-EVs correspond to glomerular urinary-space aggregates. Enriching AIT-EVs enables detection and monitoring of pathogenic autoantibodies, suggesting a non-invasive approach for autoimmune kidney disease diagnosis and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesAutoantibodiesGlomerulonephritis, MembranousAutoimmune DiseasesHumansAnimalsCell MembraneMiceExtracellular VesiclesMaleFemale

Stichwörter der Autor:innen

14-3-3ADAM10PLA(2)R1THSD7Aautoantibodyclearanceextracellular vesiclefoot process effacementmembranous nephropathypodocyte

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Institute of Cellular and Integrative Physiology, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany; Hamburg Center for Kidney Health, UKE, 20246 Hamburg, German…
  • Institute of Medical Systems Bioinformatics, Center for Biomedical AI, Center for Molecular Neurobiology, Center for Translational Immunology, German Center for Child and Youth Health, UKE, 20246 Hamburg, Germany.
  • Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany.
  • HistoDigital (HiD) UG, 91058 Erlangen, Germany.
  • Cell Communication and Migration Laboratory, Institute of Biochemistry and Molecular Cell Biology, Center for Experimental Medicine, UKE, 20246 Hamburg, Germany.
  • Biochemical Institute, Christian Albrechts-University, 24018 Kiel, Germany.

Förderung

  • Human Frontier Science Program
  • German Research Foundation

Zitieren

APA

Lahme, K., Sachs, W., Froembling, S., Loreth, D., Böttcher-Dierks, V., Neumann, K., Hann, F. M., Arkan, N., Brehler, M., Reichelt, J., Sgries, A., Surmann, K., Gaffling, S., Adler, M. R., Sáez, P. J., Wedekind, U., Lampert, A., Tasika, E., Saftig, P., …, & Meyer-Schwesinger, C. (2026). Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease. Cell, 189(1), 123-142.e30. https://doi.org/10.1016/j.cell.2025.11.010

Vancouver

Lahme K, Sachs W, Froembling S, Loreth D, Böttcher-Dierks V, Neumann K, et al. Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease. Cell. 2026;189(1):123-142.e30. doi:10.1016/j.cell.2025.11.010

BibTeX
@article{Lahme2026,
  author = {Lahme, Karen and Sachs, Wiebke and Froembling, Sarah and Loreth, Desiree and Böttcher-Dierks, Vincent and Neumann, Katrin and Hann, Frederik-Michael and Arkan, Nick and Brehler, Michael and Reichelt, Julia and Sgries, Antonia and Surmann, Kristin and Gaffling, Simone and Adler, Marie R and Sáez, Pablo J and Wedekind, Uta and Lampert, Alina and Tasika, Elena and Saftig, Paul and Conze, Christian and Thünauer, Roland and Skuza, Sinah and Neitzel, Karen and Zielinski, Stephanie and Brand, Johannes and Bonn, Stefan and Michalik, Stephan and Völker, Uwe and Zimmermann, Marina and Wiech, Thorsten and Meyer, Tobias N and Fester, Lars and Meyer-Schwesinger, Catherine},
  title = {Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {1},
  pages = {123--142.e30},
  doi = {10.1016/j.cell.2025.11.010}
}
Kostenlos starten →